BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20525909)

  • 1. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.
    Anawalt BD
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2614-7. PubMed ID: 20525909
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of testosterone replacement therapy.
    Med Lett Drugs Ther; 2016 Mar; 58(1490):33-4. PubMed ID: 26963153
    [No Abstract]   [Full Text] [Related]  

  • 3. A response to the letter by NAMS regarding the role of testosterone therapy in postmenopausal women.
    Tiefer L
    MedGenMed; 2005 Nov; 7(4):51; author reply 50. PubMed ID: 16614673
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient information page from The Hormone Foundation. Patient guide to testosterone therapy in adult men with androgen deficiency syndromes.
    Bhasin S; Matsumoto AM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2p following 3085. PubMed ID: 20540171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
    Rochoy M; Thomas R; Béné J; Deleplanque D; Vantyghem MC; Gautier S; Deplanque D;
    Prog Urol; 2018 May; 28(6):315-321. PubMed ID: 29650456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
    McGill JJ; Shoskes DA; Sabanegh ES
    Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certainly more guidelines than rules.
    McLachlan RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2610-3. PubMed ID: 20525908
    [No Abstract]   [Full Text] [Related]  

  • 9. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrinology Update: Testicular Hypogonadism.
    Heidelbaugh JJ
    FP Essent; 2016 Dec; 451():31-41. PubMed ID: 27936533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and cardiovascular disease in postmenopausal women: a systematic review.
    Spoletini I; Vitale C; Pelliccia F; Fossati C; Rosano GM
    Climacteric; 2014 Dec; 17(6):625-34. PubMed ID: 24559253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens and breast cancer.
    Kotsopoulos J; Narod SA
    Steroids; 2012 Jan; 77(1-2):1-9. PubMed ID: 22015396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone use in women: how safe is it?
    Tan RS; Teoh SH
    Curr Drug Saf; 2013 Apr; 8(2):120-7. PubMed ID: 23713539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
    Ta V; Chin WK; White AA
    Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
    [No Abstract]   [Full Text] [Related]  

  • 18. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer].
    Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM
    Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen replacement therapy in aging men.
    Katz A
    Nurse Pract; 2004 Oct; 29(10):58-64. PubMed ID: 15489672
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.